Phase I study of the safety and efficacy of INC280 in patients with advanced MET-dependent solid tumors.
Yung-Jue Bang
Disclosure not yet available
Wu-Chou Su
Disclosure not yet available
Do-Hyun Nam
Disclosure not yet available
Wan-Teck Lim
Disclosure not yet available
Todd Michael Bauer
Disclosure not yet available
Irene Brana
Disclosure not yet available
Ronnie Tung-Ping Poon
Disclosure not yet available
David S. Hong
Disclosure not yet available
Chia-Chi Lin
Disclosure not yet available
Bin Peng
Disclosure not yet available
Yingxi Zhang
Disclosure not yet available
Sylvia Zhao
Disclosure not yet available
Arun Kumar
Disclosure not yet available
Mikhail Akimov
Disclosure not yet available
Brigette Ma
Disclosure not yet available